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ABSTRACT 
 
Mitochondrial Function and Homeostasis Regulated by Asymmetric 
Arginine Dimethylation 
 
by 
 
Liang Sha, Ph.D. candidate 
University of Tsukuba, 2016 
 
Primary Supervisor: Shoji Makino, Ph.D. 
Vice Supervisor: Akiyoshi Fukamizu, Ph.D. 
                            Margarete Heck, Ph.D. 
 
Purpose 
Protein Arginine Methyltransferase 1 (PRMT1) catalyzes asymmetric arginine 
dimethylation on cellular proteins and modulates various aspects of cellular 
processes, such as signal transduction, DNA repair, and transcriptional 
regulation. We have previously reported that prmt-1 is an anti-ageing factor in 
C. elegans (Cell Metab. 13, 505-516, 2011) and accumulating evidence has 
shown that it is involved in a broad spectrum of ageing-related diseases, such as 
myocardial infarction (Acta Histochemica 112, 413-423, 2010) and 
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hypomyelination-induced neurodegenerative diseases (J. Biol. Chem. 291, 
2237-2245, 2016). However, the physiological and pathological roles of PRMT-
1 remain largely unclear because of the lack of in vivo investigation. In this 
study, we employed C. elegans as a model organism to explore the 
physiological functions of PRMT-1 at whole-organism level. 
 
Materials and methods 
Animals: Bristol N2 wild-type, RB2047 prmt-1(ok2710), TKB71 
trcEx71[prmt-1(+);Pmyo2::DsRed];prmt-1(ok2710), TKB84 trcEx84[prmt-
1G70A(+);Pmyo2::DsRed];prmt-1(ok2710), and SJ4100 zcIs13[hsp-6::GFP] 
were used.  
Plasmids: Full-length cDNAs encoding C. elegans hsp-60, atp-2, Y38F1A.6, or 
daf-16 were amplified by PCR and then cloned into pGEX-6P(5X) vector. 
FLAG tagged C. elegans PRMT-1 was inserted into pcDNA3 vector for 
mammalian cell expression.  
Two-dimensional electrophoresis (2-D PAGE): Whole body extracts from N2 
or prmt-1(ok2710) were subjected to 2-D PAGE and followed by Western blot 
against ASYM24 or ASYM26 antibody to detect asymmetrically arginine-
dimethylated proteins.  
GST pull-down assay and in vitro methylation: Immobilized GST fusion 
proteins were incubated with FLAG-PRMT-1 to examine the protein-protein 
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interaction, or to assess the potential of being substrates in the presence of S-
adenosyl-L-[methyl-3H]methionine.  
Mitochondrial fractionation: mitochondria were isolated by differential 
centrifugation.  
LC-MS/MS: asymmetric or symmetric dimethylarginine (ADMA or SDMA) 
levels of mitochondrial fractions were quantified by LC-MS/MS.  
in vitro ATP assay: ATP producing function of mitochondria was assessed by 
in vitro ATP assay based on luciferin-luciferase reaction.  
MitoSOX staining: mitochondrial ROS generation was examined by whole 
body staining with MitoSOX fluorescent probe.  
real-time RT-PCR: expression levels of mitochondria-related or stress 
response genes were measured by real-time RT-PCR.  
RNAi feeding: genes were selectively silenced by feeding the worms with 
HT115 E. coli harboring target gene fragments.  
Food avoidance assay: worms were fed on 3.5 cm plates seeded with a limited 
area of normal or knockdown bacteria lawn, and the ratio of off-lawn worms 
was scored. 
 
Results 
In this study, nine in vivo substrates of PRMT-1 were identified by two-
dimensional Western blot-based proteomic analysis using C. elegans. The 
subcellular localizations of these substrates spans from extracellular matrix, 
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cytoplasm, nucleus, to organelles such as endoplasmic reticulum and 
mitochondria. Because the direct relation between PRMT-1 and mitochondrial 
functions has never been reported, we therefore focused on the function of 
PRMT-1 in mitochondria. Subcellular fractionation followed by LC-MS/MS 
analysis showed that PRMT-1 is almost entirely responsible for asymmetric 
arginine dimethylation on mitochondrial proteins. Metabolome analysis showed 
a global suppression of metabolism in prmt-1 deletion mutants, however, the 
mitochondrial biogenesis was not seemed to be altered. Importantly, isolated 
mitochondria from prmt-1-null mutants represent compromised ATP synthesis 
probably due to decreased activity of oxidative phosphorylation in vitro. 
Transgenic rescue experiments demonstrate that PRMT-1-dependent 
asymmetric arginine dimethylation is required to prevent mitochondrial ROS 
production in C. elegans. Furthermore, prmt-1-null mutation causes induction 
of stress response genes involving xenobiotic-detoxification and innate immune 
defense, as well as the metabolic process and mitochondrial genes. Direct 
evidence for the mitochondrial stress was observed with the activation of 
mitochondrial unfolded protein response. As the behavioral response, prmt-1 
mutant worms exhibited food-avoidance behavior due to mitochondrial 
dysfunction. 
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Discussion 
Our discovery uncovered a novel role of PRMT-1 which facilitates the energy 
metabolism and also maintains the homeostasis of mitochondria by directly 
targeting mitochondrial proteins. These findings are expected to provide clues 
for understanding the physiological roles of PRMT-1 in higher organisms and 
add new layer of complexity to posttranslational regulation of mitochondrial 
function, ultimately contributing to the mechanismic or therapeutic research of 
mitochondria-related disorders, including cardiovascular and neurodegenerative 
diseases. 
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     CHAPTER 1 
INTRODUCTION 
 
I. Protein Arginine Methylation 
1. Protein Arginine Methylation 
Post-translational modifications provide important regulations on almost 
all aspects of biology. In addition to phosphorylation and acetylation, 
methylation is another major modification that closely controls protein 
function. A wide variety of methylation reactions occur at the side chains 
of a number of amino acid residues and at protein N and C termini (5). 
Arginine methylation is extensively happening on various proteins. 
Arginine is unique among amino acids as its guanidino group contains 
five potential hydrogen bond donors that are positioned for favorable 
interactions with biological hydrogen bond acceptors in protein-DNA or 
protein-RNA interactions (1-5). Methylation on arginine residues 
removes potential hydrogen bond donors. This chemical adduct also 
affects the protein-protein interactions. 
Arginine methylation can be classified into three categories (5): omega-
NG,NG-dimethy-larginine that two methyl groups are added on one of the 
terminal nitrogen atoms of the guanidino group; this derivative is 
commonly referred to as asymmetric dimethylarginine (ADMA) which is 
the most abundant arginine methylation in mammalian cells. The other 
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two forms of arginine methylation includes: omega-NG,N’G-
dimethylarginine (SDMA)  and the omega-NG-monomethylarginine 
(MMA). 
 
2. PRMTs 
The formation of MMA, ADMA, and SDMA in mammalian cells 
is catalyzed by a family of protein arginine methyltransferases, namely, 
PRMTs. The PRMT family members share some structural features: each 
member harbors the characteristic motifs of seven-beta strand 
methyltransferases, as well as additional ‘‘double E’’ and ‘‘THW’’ 
sequence motifs (5). Generally, the PRMT family members are 
responsible for catalyzing first the formation of a MMA as an 
intermediate, and subsequently type I enzymes including PRMT1, -2, -3, 
-4, -6, and -8, further catalyze the generation of ADMA, while type II 
enzymes including PRMT5, PRMT7, and FBXO11 catalyzes the 
generation of SDMA. PRMT1, -3, -4 (CARM1), -6 and -8 additionally 
catalyze ADMA formation, whereas PRMT5 additionally catalyzes 
SDMA formation (1-5). A clear understanding of how PRMT catalytic 
polypeptides can be assembled into active complexes with other protein 
subunits in cells is needed. Although PRMT1, -3, -4 (CARM1), -5, -6, 
and -8 are active methyltransferases in the absence of other polypeptide 
species in vitro, they might also bind additional partners for their 
 12 
functions in vivo (5). It now appears that interactions between PRMTs 
and their binding partners (and presumed regulatory subunits) can be 
transient or permanent. Since ADMA is the prevalent species in arginine 
methylation, and PRMT1 has been shown to be the predominant enzyme 
for ADMA formation in mammalian cells, PRMT1 has been closely 
focused in arginine methylation study. 
 
3. Molecular Functions of Asymmetric Arginine Dimethylation 
Accumulating evidence has shown that asymmetric arginine methylation 
is involved in a broad spectrum of cellular events, such as transcriptional 
regulation, RNA splicing, DNA repair, and signal transduction (1-5). The 
most extensively studied function of asymmetric arginine methylation is 
its transcriptional regulatory function for the modification on histone tail 
or other histone modifying enzymes. For example, the histone H4R3 site 
is a major target for PRMT1 methylation (ADMA) and is generally 
regarded as a transcriptional activating mark (5). The vast majority of 
PRMT substrates are associated with RNA, including heterogeneous 
nuclear ribonucleoproteins (hnRNPs) and ribosomal proteins. Thus, 
arginine methylation has been implicated in all aspects of RNA 
metabolism, including mRNA transcription, splicing, transport, 
translation, and turnover (1-5). Another important aspect of the functions 
of asymmetric arginine dimethylation on cellular proteins is that it 
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modulates signal transduction. An impressive example is the methylation 
of FOXO1 antagonizes the phosphorylation by Akt, which facilitates the 
nuclear translocation of FOXO1 and enhances the expression of its 
downstream genes (1). 
 
4. Physiological and Pathological Relevance of Asymmetric Arginine 
Dimethylation 
Although the molecular functions of asymmetric arginine dimethylation 
has been extensively studied, the physiological and pathological 
relevance of this modification remains largely unknown. It is partially 
because of the lack of in vivo evidence that the identified substrates of 
PRMT1 are methylated. Another point that obstructs the in vivo 
functional study of asymmetric arginine dimethylation is that the genetic 
deletion of PRMT1 in either mouse or fruit fly leads to an embryonic 
lethal phenotype. However, recently the tissue-specific knockout of 
PRMT-1 in mice gave important hints of its physiological and 
pathological relevance. For example, our previous work showed that 
conditional knockout of PRMT1 in central neuron system caused severe 
hypomyelation of mouse neuron cell, which is closely related to various 
neuronal degradative diseases, connecting the physiological function of 
PRMT1 to neuronal development (30). However, the underlying 
mechanisms for the phenotype was unknown in the study, due to the 
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undiscovered responsible substrates. Therefore, the gap between the 
revealed molecular functions of asymmetric arginine methylation and its 
physiological or pathological relevance requires the identification of in 
vivo substrates of PRMT1. 
 
II. Mitochondria 
1. Mitochondria and ATP Synthesis 
Mitochondria plays essential roles in cellular metabolism. It consists of 
outer membrane, inner membrane, the intermembrane space, and the 
matrix. In the matrix, tricarboxylic acid cycle (TCA) enzymes extract 
energy from different energy sources and store it in the electron carriers 
(NADH and FADH2), which then donate electrons to the inner 
membrane localized electron transport chain (ETC). The ETC consists of 
four protein machines (I–IV), which through sequential redox reactions 
undergo conformational changes to pump protons from the matrix into 
the intermembrane space (45). The proton gradient generated by 
complexes I, III, and IV is released through the rotary turbine-like ATP 
synthase machine or complex V, which drives phosphorylation of ADP to 
ATP (45).  
On the other hand, mitochondria are the major place for cellular reactive 
oxygen species (ROS) generation which in mitochondria is produced as a 
byproduct of OXPHOS. ROS has been suggested to contribute to diseases 
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associated with mitochondrial dysfunction, including neurodegenerative 
or cardiovascular diseases. 
 
2. Mitochondrial Stress and Unfolded Protein Response 
Organisms have evolved sophisticated systems to monitor mitochondrial 
functions and maintain its homeostasis through communication between 
mitochondria and nucleus (2). One of these mitochondrial systems is a 
conserved protein quality control termed mitochondrial unfolded protein 
response (UPRmt), in which the accumulation of unfolded protein within 
the mitochondrial matrix leads to the transcriptional activation of nuclear 
genes encoding mitochondrial chaperones and proteases to help protein 
folding, assembly, and clearance of defective proteins in stressed 
mitochondria (3–5). In C. elegans, disruption of mitochondrial function 
activates not only UPRmt, but also xenobiotic-detoxification and 
pathogen-response pathways, suggesting that animals interpret an 
impaired mitochondrial activity as xenobiotic exposure or pathogen 
attack (6–8). Actually, C. elegans displays bacterial-avoidance behavior 
when mitochondria are inhibited by RNAi or an antibiotic such as 
antimycin even in the absence of pathogen attack (7, 8). This intrinsic 
protective behavior termed food-avoidance is also found in Drosophila 
melanogaster (9) and reminiscent of mammalian gastrointestinal 
responses to enteric pathogens that trigger nausea symptom (10). 
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3. Post-translational Modifications of Mitochondrial Proteins 
Accumulating evidence has demonstrated that mitochondrial proteins 
undergo several posttranslational modifications, such as acetylation and 
phosphorylation (11, 12). For example, an estimated 35% of all 
mitochondrial proteins are acetylated with the highest enrichment in 
OXPHOS and tightly regulated by reversible acetylation (13). 
Interestingly, arginine methylation has recently emerged as new 
regulatory posttranslational modification in mitochondrial proteins; 
namely, NDUFS2, a subunit of mitochondrial complex I, is 
symmetrically dimethylated at arginine 85 by a predicted 
methyltransferase NDUFAF7 in the matrix of mitochondria and this 
methylation is required for assembly of complex I (14). In addition, it has 
been also reported that NDUFAF7-induced symmetric dimethylation of 
NDUFS2 is essential for normal vertebrate development (15). On the 
other hand, the responsible enzyme for asymmetric arginine 
dimethyaltion on mitochondrial proteins and the biological roles of this 
major arginine methylation (16, 17) in mitochondrial functions remain 
largely unknown. 
 
4. Mitochondrial Diseases 
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A major milestone of the research for neuronal degradative or 
cardiovascular disorders was that the discovery of the connection 
between these diseases and mitochondrial dysfunction. Genetic 
investigation revealed that most of the mitochondria-related disorders 
arise from the defects in mitochondrial genome or nuclear genome (46). 
Indeed, most of the proteins that built the mitochondria are coded by 
nucleus. The tissues or cell types such as neurons, cardiac or skeletal 
muscle, have the most abundant mitochondria and are highly dependent 
on the mitochondrial bioenergetics, thus being extremely sensitive to 
mitochondrial dysfunction. Mitochondria-related diseases can be 
categorized into three classes: primary mitochondrial DNA mutations 
such as Pearson syndrome, mitochondrial-protein-coding nuclear gene 
mutations such as Leigh’s syndrome, and mutations in mitochondrial 
regulatory genes such as Parkinson’s disease (46). Interestingly, the gene 
ontology (GO) analysis showed that the acetylated mitochondrial proteins 
are largely enriched in metabolic pathways related to mitochondrial 
diseases (20). Considering that abnormality with PRMT1 is related with 
neurodegradative or cardiovascular diseases, it is possible that PRMT1 
plays roles in mitochondrial functions. 
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CHAPTER 2 
MATERIALS AND METHODS 
 
C. elegans strains. All strains were maintained and handled according to 
standard methods. Briefly, nematodes were maintained on NGM OP50 plates at 
20°C. Bristol N2 wild-type, RB2047 prmt-1(ok2710), and SJ4100 zcIs13[hsp-
6::GFP] were obtained from the Caenorhabditis Genetics Center and the prmt-
1(ok2710) mutant was outcrossed to N2 three times (18). The 
extrachromosomal prmt-1 wild-type and G70A mutant-overexpressing lines in 
prmt-1(ok2710) background were TKB71 trcEx71[prmt-
1(+);Pmyo2::DsRed];prmt-1(ok2710) and TKB84 trcEx84[prmt-
1G70A(+);Pmyo2::DsRed];prmt-1(ok2710), respectively (19). 
 
Feeding RNAi. For RNAi constructs against prmt-1 and isp-1, the 500 bp 
of each coding sequence was amplified by PCR and cloned into L4440 vector. 
The following primers were used: prmt-1 RNAi, the forward (5’-
ACCTTACCATGGCAGCTTCTCCGTGACAA-3’) and the reverse (5’-
GTATTCTGCAGCTTGGGGGTGTTTCGA-3’); isp-1 RNAi, the forward (5’-
ACCTTACCATGGCAGCTTCTCCGTGACAA-3’) and the reverse (5’-
GTATTCTGCAGCTTGGGGGTGTTTCGA-3’). The RNAi clones against 
prmt-5, inx-17, and thoc-2 were obtained from the Ahringer library. All RNAi 
constructs were transformed into HT115 E. coli and then seeded onto NGM 
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plates containing 25 g/ml carbenicillin and 1 mM IPTG for feeding RNAi 
experiments. 
 
Plasmid construction and antibodies. Full-length cDNAs encoding C. 
elegans hsp-60, atp-2, and Y38F1A.6 were amplified by PCR and then cloned 
into pGEX-6P(5X) vector. Expression vectors for C. elegans daf-16 and prmt-1 
were described previously (9). The following antibodies were purchased: anti-
dimethyl-Arginine Antibody, asymmetric (ASYM24) from Merck Millipore; 
anti-dimethyl-Arginine Antibody, asymmetric (ASYM26) from EpiCypher; 
anti--Tubulin (T5168) and anti-FLAG M2 (F1804) from Sigma-Aldrich; anti-
GFP (#2956) and anti-Histone H3 (#4499) from Cell Signaling Technology; 
anti-ATP5A (ab14748) and anti-ATPB (ab14730) from abcam. A rabbit 
polyclonal antibody against PRMT-1 was raised by using synthetic peptide 
described previously (9). 
 
GST pull-down assay. GST fusion proteins were expressed in BL-21 E. 
coli by using the pGEX vector system. GST alone or GST-fused proteins 
immobilized on glutathione-Sepharose 4B were incubated with HEK293T cell 
extracts expressing FLAG-PRMT-1 in binding buffer (50 mM Hepes, pH7.9/ 
150 mM NaCl/ 0.1% TritonX-100/ protease inhibitors). After incubation for 4 
hrs at 4°C, the beads were washed three times with the same buffer, and 
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proteins were analyzed by Coomassie Brilliant Blue staining and Western 
blotting with anti-FLAG antibody. 
 
In vitro methylation assay. FLAG-tagged PRMT1 was immunoprecipitated 
from HEK293T cells with anti-FLAG M2 affinity gel, and then eluted with 
FLAG peptide. Eluted PRMT-1 was combined with GST alone or GST-tagged 
HSP-60, ATP2, and Y38F1A.6 in the presence of 5 μCi of S-adenosyl-L-
[methyl-3H]methionine (NET155V, specific activity 666 GBq/mmol; 
PerkinElmer) in 30 μl of PBS, and reactions were incubated for 3 h at 30°C. 
After washing the beads, the reaction products were resolved by SDS-PAGE, 
and radioactively labeled proteins were visualized by fluorography with 
Amplify fluorographic reagent (GE Healthcare). 
 
Two-dimensional Western blot and protein identification. Whole body 
extracts from N2 or prmt-1 mutant worms were obtained by homogenizing 20 
L of wet packed worms in 2-DE buffer (7M urea, 2M thiourea, 30 mM Tris, 
4% CHAPS, 0.01% Triton X-10, 60 mM DTT) with protease inhibitor cocktail 
(Nacalai tesque) using sonication. After centrifugation, proteins were 
precipitated with methanol/chloroform and re-suspended in 2-DE buffer. Three 
hundred microgram of protein was separated with 75 mm pH 5–8 agarose stick 
gel followed by 10% SDS-PAGE gel. The resulted gels were either stained with 
Sypro Ruby (BioRad) fluorescent dye or transferred to PVDF membrane and 
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blotted with ADMA antibodies. N2 specific Western blotting spots were picked 
out from Sypro Ruby gel after merging the two staining results. 
Detected PRMT-1 substrates were identified with MALDI-TOF/MS 
according to the protocol previously reported (20). Stained protein spots were 
excised and dehydrated with acetnitrile, and then reduced and alkylated with 
DTT and iodoacetamide before tryptic digestion in situ. Tryptic peptides were 
desalted by binding and then elution from a C18 Zip-tip (Millipore), and then 
mixed with -cyano-4-hydroxycinnamic acid (Wako) matrix and spotted onto 
the stainless steel plate. The dried spots were analyzed by MALDI-TOF mass 
spectrometry (ultrafleXtreme, Bruker). The resulted peptide peaks were 
manually picked up, and the masses of the peptides were used for protein 
identification through MASCOT peptide mass fingerprint matching. The 
MASCOT scores larger than 57 are considered significant. 
 
Mitochondrial fractionation. Worms were allowed to grow until young 
adult stage and harvested with M9 buffer. After clearance with sucrose 
flotation, worms were homogenized by using dounce homogenizer in five-time 
volume of mitochondria isolation buffer (MIB: 210 mM mannitol, 70 mM 
sucrose, 0.1 mM EDTA, 5 mM Tris, and protease inhibitor cocktail). The 
homogenates were centrifuged at 1,000 g for 10 min. The supernatants were 
saved, and the pellets were re-suspended in the same volume of MIB and 
homogenized again. After centrifuged at 1,000 g for 10 min, an aliquot of the 
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combined supernatants was saved as total lysate (TL). The rest of supernatants 
were centrifuged at 5,000 g for 10 min. The pellets were washed twice by re-
suspending in 1 mL MIB and centrifuged at 2,000 g for 10 min. After the 
combined supernatants were centrifuged again at 2,000 g for 10 min, the heavy 
mitochondria (HM) were pelleted by centrifuging the supernatants at 15,000 g 
for 10 min and re-suspended in MIB. The supernatants from 5,000 g 
centrifugation were further centrifuged at 15,000 g for 10 min and the resulted 
supernatants were aliquoted as post-mitochondria supernatants (PMS). The 
pellets were washed by re-suspending in MIB and centrifuging at 5,000 g for 10 
min. The light mitochondria (LM) were pelleted by centrifuging again at 15,000 
g for 10 min and re-suspended in MIB. 
The mitochondria used for in vitro ATP assay were isolated according to a 
simplified protocol as previously described (21). 
 
Acid hydrolysis and LC-MS/MS. Acid hydrolysis of worm proteins was 
performed essentially as previously described (Kanou et al., submitted). Briefly, 
after mitochondrial fractionation, each fraction of worm proteins (50 mg) were 
hydrolyzed with 6 N HCl at 110°C for 24 hrs in glass vials. N-propyl-L-arginine 
(N-PLA, SIGMA-Aldrich) was added as the internal control. 
ADMA or SDMA were quantified using a Shimadzu NexeraTM ultra high-
pressure liquid chromatography system coupled to LCMS-8050TM triple 
quadrupole mass spectrometer (Shimadzu, Kyoto, Japan) as described 
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previously (Hashimoto et al. 2016). LC separation was performed on a SeQuant 
TM ZIC-HILIC TM column (2.1 × 150 mm, Merck KGaA, Darmstadt, 
Germany) with a SeQuant TM ZIC-HILIC TM Guard Fitting (1.0 × 14 mm, 
Merck KGaA) at 40 °C. Acetonitrile/water/formic acid (1:98:1) (A) and 
acetonitrile/water/formic acid (98:1:1) (B) were used as mobile phases, water-
dissolved sample (1 L) was injected and eluted with the followed gradient 
elution program: 95% B for 1 min, shifted to 5% in 9 min, and kept 5% for 4 
min. The system was allowed to equilibrate for 7 min at 95% B prior to the next 
analysis. The flow rate was 0.2 mL/min. 
   Mass spectroscopy operating conditions were optimized as follows: 
interface voltage, 4.00 kV; interface current, 0.55 V; interface temperature, 
300 ˚C; desolvation line temperature, 250 ˚C; heating block temperature, 400 
˚C; drying gas (N2); 10 L / min; nebulizing gas (N2); 3 L / min; heating gas 
(air), 10 L / min; and collision-induced dissociation gas (argon), 230 kPa; 
conversion dynode potential, -10.00 kV; detector potential, -2.20 kV. Multiple 
reaction monitoring was used for detection of arginine derivatives with a dwell 
time to 100 ms. Q1 was set to transmit the parental ions MH+ at m/z 203.15 for 
ADMA, SDMA, and 324.6 for N-PLA. The daughter ions were monitored in 
Q3 at m/z 158.05, 171.95 and 70.15 for ADMA, SDMA and, N-PLA, 
respectively. All analyses and data processing were completed with the 
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LabSolutions Ver. 5.60 software (Shimadzu Scientific Instruments, Inc., 
Columbia, MD).  
 
In vitro ATP assay. The protein concentrations of isolated mitochondria 
were measured by DC protein assay (BioRad) and adjusted to 0.2 mg/mL with 
buffer B (225 mM sucrose, 44 mM KH2PO4, 12.5 mM Mg acetate, and 6 mM 
EDTA). Commercially purchased ADP (Wako) was incubated with glucose and 
hexokinase to deplete the residual ATP contamination before use. After 
reaction, the hexokinase was inactivated by heating to 99°C for 3 min. In vitro 
ATP assay was conducted in 96-well plate (Corning) with every sample 
measured in triplicate. Twenty microliters of different combinations of 
intermediate metabolites (PM: 5 mM pyruvate + 5 mM malate; SM: 25 mM 
succinate + 5 mM malate; GM: 50 mM glutamate + 25 mM malate; PCM: 0.25 
mM palmitoyl-L-carnitine + 10 mM malate) and 10 L of 1 mM ADP were 
added to the wells, followed by 20 L of isolated mitochondria or buffer B as 
background. The produced ATP was measured based on luciferin/luciferase 
reaction by ATP Bioluminescence Assay Kit HS II (Roche) under the 
manufactories’ instructions. After 50 L of luciferase reagent was added to the 
reaction, the luminescence was read by Wallac 1420 ARVOsx multilabel 
counter (Winpact Scientific) at different time points. 
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MitoSOX staining and imaging. Adult worms were wounded by 
microinjection needles to increase the permeability of MitoSOX Red molecular 
probe (Invitrogen). After wounding, worms were immediately transferred to 
MitoSOX Red staining solution (5 μM in M9, prepared from a 5 mM stock in 
DMSO before use) and stained in the dark with for 20 min at room temperature. 
Stained worms were washed three times with M9 before imaging under 
fluorescent microscope with DsRed filter. 
 
Food-avoidance assay. Food-avoidance assay was performed as previously 
described (8). Briefly, one milliliter of overnight culture of RNAi E. coli was 
pelleted and re-suspended in 50 L of LB, then dropped in the center of 3.5-cm 
dishes containing 1 mM IPTG. For NGM dishes, 50 L of OP50 was seeded. 
Dried dishes were kept at room temperature overnight to allow the IPTG 
induction. Only circular lawns of uniform size and density were used for food-
avoidance assays. Synchronized L1 worms (about 50 animals per dish) were 
dropped into the center of each bacterial lawn. Food-avoidance phenotypes 
were scored when the worms grow to the young adult stage. 
 
RNA extraction and quantitative RT-PCR. Synchronized L1 worms were 
allowed to grow to L4 stage and collected. Worms were then washed with M9 
buffer and re-suspended in ISOGEN (Nippon Gene). After three cycles of 
freeze/thaw, worms were incubated at room temperature for 5 min. Worm 
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debris was removed by centrifugation at 13,200 rpm for 15 min at 4°C. Total 
RNA was obtained by isopropanol precipitation and RQ1 RNase-free DNase 
(Promega) treatment. Five-hundred ng of total RNA was reverse transcribed 
using ReverTra ace kit (TOYOBO) and then real-time quantitative PCR 
reactions were performed on a Thermal Cycler Dice using a SYBR Premix Ex 
Taq II (TaKaRa). Relative gene expression was determined by ΔΔCT method. 
Primers used for amplifications were as follows: 
act-1, the forward (5'-GGTTGCCGCTCTTGTTGTAG-3') and the reverse (5'-
CTTCTGTCCCATACCGACCA-3'); cyp-34a2, the forward (5’-
TTTGAAACATGCGCCCGCTC-3’) and the reverse (5’-
CGCGTCGTCCTGTTCAAACC-3’); cyp-14a5, the forward (5’-
ACGCCTTTGTCAATCGTGCC-3’) and the reverse (5’-
CCTGCCCAAGCCAAAATCCC-3’); ugt-31, the forward (5’-
TTGCGGACACACTGACCGAG-3’) and the reverse (5’-
CACACCGATTTCGTGCCTCC-3’); ugt-26, the forward (5’-
AGCCCGAGGATTTCAGCTCAG-3’) and the reverse (5’-
TGCATCGAACAGTTTGGCGAG-3’); gst-24, the forward (5’-
CACCCCACTACGCCAACTCA-3’) and the reverse (5’-
GCGCGAAGACCTCCTTTTGG-3’); gst-29, the forward (5’-
CTCGTTGGAGATGGGCTCACA-3’) and the reverse (5’-
GAGCTGCCAATTTCGGGTGC-3’); cyc-1, the forward (5’-
AGGACGGAACACCAGCAACA-3’) and the reverse (5’-
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GTCATGGAATGGCTCTGCGG-3’); cco-1, the forward (5’-
AGCCTCGCCAGAAGACTACG-3’) and the reverse (5’-
TCTCCAGCAAGACGAGCGAG-3’); atp-5, the forward (5’-
ACTGGTCGAAGCTCGCCGAG-3’) and the reverse (5’-
ACTCGGCTGGAACCTCTCCG-3’). 
 
Mitochondria to body mass ratio. Non-gravid young adult worms were 
collected and wet packed mass was measured as the body mass. Mitochondria 
was isolated as described above and resuspended in 100 L of MIB. The 
mitochondrial protein concentrations were measured by DC protein assay to 
obtain the mitochondrial mass. The ratio between mitochondrial and body mass 
was calculated. 
 
Metabolome analysis. Synchronized, arrested L1 worms were transferred to 
NGM plates seeded with OP50 and harvested on adult day 1 stage. The mass of 
wet packed worms was measured, and 30.64 mg of N2 or 47.51 mg of prmt-
1(ok2710) were sent to Human Metabolome Technologies Co. (Japan), the 
metabolites were extracted by methanol/chloroform and subjected to 
metabolome analysis by capillary electrophoresis-time of flight mass 
spectrometry (CE-TOFMS). The detected 208 metabolites (110 cations and 98 
anions) were clustered according to the metabolic pathways and drawn in the 
heatmap. 
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DNA microarray. Total RNA was prepared from N2 or prmt-1(ok2710) mutant 
worms as described above and sent to Hokkaido System Science Co Ltd. 
(Japan) for cDNA microarray based gene expression profiling. For data 
analysis, genes with the expression levels over two-fold increase in prmt-1 
(ok2710) relative to N2 were extracted and functionally classified through 
Database for Annotation, Visualization, and Integrated Discovery (DAVID). 
The enriched functional groups with p value less than 0.05 were considered 
significant. The relative expression levels of metabolism processing related 
genes or mitochondrial function related genes were normalized by Cluster 3.0 
and plotted in heatmaps with Java TreeView. 
 
Statistical analysis. Results were presented as mean ± standard error of the 
mean (SEM). Statistical significances were determined by two-tailed unpaired 
Student’s t-test. Significant differences are indicated as follows: *p < 0.05, **p 
< 0.01, and ***p < 0.001.  
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CHAPTER 3 
IN VIVO SUBSTRATES IDENTIFICATION OF PRMT-1 IN C. ELEGANS 
 
Purposes 
According to previous studies (1-5), the cellular functions PRMT1 has been 
extensively explored based on the identification of its various in vitro 
substrates. However, it is doubtful that these in vitro substrates are targeted by 
PRMT1 in vivo due to the different environments for the reaction. The assembly 
of PRMT1 complex with other regulatory factors could largely change the bulk 
activity of PRMT1 or result in unbiased activity towards its preferred substrates 
according to the cellular environment. We suppose that the physiological roles 
of PRMT1 remained largely unclear at least partially due to the lack of 
knowledge of its in vivo substrates. To further explore the physiological roles of 
PRMT-1-mediated asymmetric arginine dimethylation, we attempted to 
systematically identify in vivo substrates of PRMT1.  
 
Results 
As we reported previously (19), nematode C. elegans PRMT-1 is the 
predominant type I arginine methyltransferse and its null mutant, prmt-
1(ok2710), is viable unlike lethal phenotypes of PRMT1-deficient mouse and 
Drosophila (22, 23). We therefore employed C. elegans as an ideal animal 
model for screening in vivo substrates of PRMT-1 with the strategy of two-
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dimensional (2-D) proteomic analysis (Figure 3-1) combining Sypro Ruby 
protein stain and Western blot against two distinct asymmetric dimethylarginine 
antibodies, ASYM24 (19, 24, 25) and ASYM26.  
Since different lots of antibodies may give different performance, we tested 
the two ADMA antibodies used for 2-D proteomic analysis. Whole worm 
extracts from N2 or prmt-1(ok2710) were separated by one-dimensional SDS-
PAGE and blotted with either ASYM24 or ASYM26 (Figure 3-2). Robust 
signals were detected with ASYM24 on N2 extracts, while multiple bands of 
low molecular weight were detected with ASYM26. Remarkably, the signals on 
N2 extracts greatly decreased on prmt-1(ok2710) sample with both antibodies. 
This result is in good agreement with our previous finding by high performance 
liquid chromatography (HPLC) (9), indicating that both antibodies are specific 
for ADMA-proteins. 
Two-dimensional electrophoresis (2-DE) followed by Western blot against 
ASYM24 (Figure 3-3 upper panels) or ASYM26 (Figure 3-3 middle panels) 
revealed 10 spots of proteins containing ADMA in N2 sample when compared 
to prmt-1(ok2710) mutants as a negative control. Among them, spots 1, 2, 3, 
and 4 were detected by both antibodies, while the others were specific to either 
ASYM24 or ASYM26 antibody. This result appears to be due to the difference 
in the immunogens of the two antibodies, which in turn broadens the spectrum 
of proteins allowed to be detected. Next, to identify the proteins detected by 
Western blot, the same samples separated by 2-DE were stained with Sypro 
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Ruby fluorescent dye (Figure 3-3 lower panels) and then overlapped with the 
images of Western blot. We found that nine out of ten ADMA spots have their 
corresponding spots on the Sypro Ruby staining and also show no significant 
change in their intensity between N2 and prmt-1(ok2710) mutants. These data 
suggest that the nine spots (Table 1) are bona fide candidates of ADMA 
modification in C. elegans. 
The N2 specific spots were pick out manually and digested with trypsin. 
The results of protein identification by MALDI-TOF/MS are shown in Table 1. 
The MASCOT probability scores over 57 are considered significant.  
 
Discussion 
Among the nine substrates identified in this study, Nuclear Hormone 
Receptor 12 (NHR-12) has its human version Hepatocyte Nuclear Factor 4 
gamma (HNF4) as a known substrate of PRMT1 previously. Importantly, the 
methylated arginine in HNF4 is well conserved in NHR-12 (Figure 3-4), 
indicating the functional significance of PRMT1-mediated methylation on this 
protein across different species. Although the physiological functions of another 
identified substrate, F41H10.3, are unknown in C. elegans, its homolog, 
MUCIN-2, a secretary protein found in the mucous membrane of intestine, is a 
well-characterized factor involved in the intestinal defense to enteric pathogens 
(47), raising the possibility that PRMT1 may play roles in the gastrointestinal 
mucosal barrier. It is known that RNA-binding proteins are a large group of 
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substrates targeted by PRMTs (5) including ribosomal proteins (5). The 
methylation on RPS3 by PRMT1, RPS2 by PRMT3, and RPS10 by PRMT5 
have been shown to be related with ribosomal assembly or biogenesis, 
suggesting that the modification of RPS4 and RPL4 by PRMT-1 may play 
similar roles in C. elegans. Surprisingly, the current results of 2-D proteomic 
study revealed substrates with elusive subcellular localizations including 
endoplasmic reticulum (ER) and mitochondria, indicating asymmetric arginine 
dimethylation may be involved in a broad spectrum of cellular processes in 
vivo. The ER specific calcium-binding molecular chaperone CRT-1 was shown 
to have multiple functions in C. elegans such as preventing protein aggregation 
during heat shock or suppressing necrotic cell death, and be important for 
normal fertility or development. The asymmetric arginine dimethylation of 
CRT-1 can therefore exert regulatory effects on its functions. Notably, three 
mitochondrial proteins, HSP-60, ATP-2, and Y38F1A.6, were found to be 
potential substrates of PRMT-1 in vivo. Among them, HSP-60 is a 
mitochondria-specific chaperone which facilitates mitochondrial protein folding 
and is induced under mitochondrial stresses (11-13). ATP-2, the beta subunit of 
ATP synthase, which holds the binding and catalyzing activity of ADP and Pi, 
is crucial for the key steps in ATP synthesis. Y38F1A.6, the putative alcohol 
dehydrogenase, is involved in the metabolism of -hydroxybutyrate (GHB) 
which is an important neurotransmitter used as psychotropic drugs.  
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Although previously several studies reported that asymmetric arginine 
dimethylation was found on mitochondrial proteins also in human cells  or 
Trypanosomes (29), the correlation between this modification and 
mitochondrial function has never been addressed. On the other hand, there is a 
growing body of evidence showing that PRMT1 is largely involved in 
mitochondria-related disorders such as cardiovascular diseases and neuronal 
degradative diseases (3, 5), while the possible mechanisms remain largely 
unknown. Therefore, the identification of the three proteins prompted us to 
further investigate the functional significance of this modification in 
mitochondria. 
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Figure 3-1 
Figure 3-1. Schematic workflow of two-dimensional (2-D) Western blot for 
identification of PRMT-1 substrate in C. elegans. Briefly, whole cell 
extracts from wild-type N2 or prmt-1(ok2710) mutants were subjected to 2-
D PAGE and blotted with anti-ADMA antibodies. N2-specific spots were 
picked out from Sypro Ruby stained gels and identified by MALDI-
TOF/MS. 
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Figure 3-2 
Figure 3-2. The two kinds of antibodies used in this study detected protein-
ADMA. Whole protein lysate from N2 or prmt-1 worms were blotted with 
ASYM24, ASYM26, PRMT-1, or Tubulin antibodies. 
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Figure 3-3 
(legend on the next page) 
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Figure 3-3. Whole cell extracts from N2 or prmt-1(ok2710) mutants on 
adult day 1 were separated by 2-D PAGE, followed by Western blotting 
with ASYM24 (upper panels) or ASYM26 (middle panels) antibodies. 
After merging with Sypro Ruby stained gels (lower panels), N2-specific 
spots detected with anti-ADMA antibodies (indicated by arrows and 
numbers) were manually picked out for MALDI-TOF/MS analysis. 
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Spot 
No. 
Protein 
Identification 
Homolog 
Fragment 
Coverage 
(%) 
MASCOT 
Probability 
Score 
UniProtKB 
Entry 
Protein 
Mass 
(kDa) 
Subcellular 
Localization 
1 
F41H10.3, 
isoform d 
Mucin-2 35 59 V6CLM1 86 Exc 
2 
NHR-12, 
isoform c 
HNF4 41 60 I2HAH0 52 Nu 
3 RPL-4 RPL4 66 100 O02056 39 Rb 
4 RPS-4 RPS4X 72 94 Q9N3X2 29 Rb 
5 HSP-60 HSPD1 53 88 P50140 60 Mt 
6 
ACT-4, 
isoform c 
ACTB 61 105 Q6A8K1 40 Cy 
7 CRT-1 CALR 58 121 P27798 46 ER 
8 ATP-2 ATP5B 43 157 P46561 58 Mt 
9 Y38F1A.6 HOT 55 75 Q9U2M4 51 Mt 
Table 1 
Protein identification of major C. elegans PRMT-1 substrates 
(legend on the next page) 
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Table 1. PRMT-1 substrate proteins revealed by 2-D WB were identified by 
mass spectrometry analysis of tryptic fragments from gel spots. Tryptic 
fragment coverage from MALDI-TOF/MS of the identified proteins is 
showed, from which a MASCOT probability score was generated. 
Probability score over 57 was considered as a significant match (p < 0.05). In 
addition, the UniProtKB entry, estimated protein mass, subcellular 
localization, and ortholog of the identified proteins are included. 
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CHAPTER 4 
A MAJOR CONTRIBUTION OF PRMT-1 TO ASYMMETRIC ARGININE 
DIMETHYLATION OF MITOCHONDRIAL PROTEINS 
 
Purposes 
In chapter 3, by taking advantage of the fact that prmt-1 is the only type I 
PRMT and its deficient mutant is alive in C. elegans, we performed 2-D 
Western blot based proteomic analysis with two distinct ADMA antibodies and 
identified 9 in vivo substrates of PRMT-1 by MALDI-TOF/MS. Direct 
interaction between the target proteins and the enzyme is usually a convincing 
evidence for the enzymatic reactions to occur. To confirm the potential of the 
three mitochondrial proteins being methylated by PRMT-1, it is necessary to 
examine the methylation signal by using purified proteins and distinct detecting 
method other than antibody under in vitro conditions. 
Furthermore, to assess the contribution of PRMT-1 to the formation of 
asymmetric arginine dimethylation on mitochondrial proteins, the mitochondria 
from N2 or prmt-1 mutant worms are to be isolated and subjected to protein-
ADMA quantification. 
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Results 
To confirm the potential of the three mitochondrial proteins being substrates 
of PRMT-1, we performed GST pull-down and in vitro methylation assays by 
using FLAG-tagged PRMT-1 purified from HEK293T cell extracts together 
with GST-fused recombinant proteins. As shown in Figure 4-1, PRMT-1 bound 
to the three mitochondrial proteins in vitro, supporting the possibility that they 
could be substrates of PRMT-1. Actually, we found that HSP-60 is methylated 
as well as the forkhead domain of DAF-16, a positive control (19), and the other 
two mitochondrial proteins ATP-2 and Y38F1A.6 are also methylated, albeit at 
a lower extent than HSP-60 (Figure 4-2). 
Next, to investigate the contribution of PRMT-1 to asymmetric arginine 
dimethylation of total mitochondrial protein in vivo, we performed subcellular 
fractionation of mitochondria from C. elegans and quantified the amounts of 
ADMA in proteins by using LC-MS/MS. Efficient isolation of light and heavy 
mitochondria from total extracts of wild-type and prmt-1(ok2710) mutants were 
verified by Western blot with organelle markers (Figure 4-3). Notably, LC-
MS/MS analysis demonstrated that prmt-1(ok2710) mutants has extremely low 
levels of ADMA in both mitochondrial fractions compared with that of N2 
(Figure 4-4). In contrast, levels of symmetric dimethylarginine (SDMA) were 
increased in light but not heavy mitochondrial fraction (Figure 4-4), which is 
partially consistent with previous observations in mouse models (17, 26). Taken 
together, these results indicate that PRMT-1 serves as the major enzyme 
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catalyzing asymmetric arginine dimethylation in mitochondria, and the loss of 
PRMT-1 alters the dynamics of SDMA formation especially in light 
mitochondrial fraction. 
 
Discussion 
In vitro experiments showing that the three mitochondrial proteins interact 
and are methylated by PRMT-1, partially confirmed the results of the 2-D 
proteomic analysis based in vivo substrate identification (Chapter 3). However, 
since the in vivo reaction context can be largely different from in vitro, we have 
scheduled to confirm the in vivo methylation of the three mitochondrial 
proteins. The modified arginine sites will be identified by MALDI-
TOF/MS/MS either from the corresponding spots on 2-D result or from the 
immunoprecipitated protein with specific antibodies. This information is 
important for the following functional study of asymmetric arginine 
dimethylation on the three mitochondrial proteins by mutagenesis. 
In consistence with our previous finding that PRMT-1 is the predominant 
type I PRMT in C. elegans, mitochondrial fractionation from either N2 or prmt-
1 mutant worms showed that PRMT-1 contributes to almost all the asymmetric 
arginine dimethylation formation on mitochondrial proteins as revealed by 
acidic hydrolysis followed by LC-MS/MS analysis. Intriguingly, Western blot 
results showed that PRMT-1 itself is not localized in mitochondria, which is in 
line with the previous knowledge that PRMT-1 is mainly localized in nucleus 
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and cytoplasm (5). Therefore, we hypothesize that PRMT-1 methylates the 
mitochondrial proteins in the cytoplasm before they translocalize into 
mitochondria. This would make the asymmetric arginine dimethylation different 
from the other post-translational modifications on mitochondrial proteins, such 
as phosphorylation and acetylation, which either are mediated by mitochondrial 
enzymes or occur spontaneously (19, 20). The modification of mitochondrial 
proteins in cytoplasm is supposed to provide extra regulations on mitochondrial 
functions including mitochondrial protein import, although the protein level of 
ATP-2 in mitochondrial fractions doesn’t seem to be altered by prmt-1 
depletion (Figure 4-3). However, whether PRMT-1 methylates its mitochondrial 
substrates directly in vivo needs to be further examined. 
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Figure 4-1 
Figure 4-1. HSP-60, ATP-2, and Y38F1A.6 bind to PRMT-1 in vitro. GST 
pull-down assay was performed with FLAG-PRMT-1 and GST, GST-HSP-
60, GST-ATP-2, or GST-Y38F1A.6, followed by Western blotting (upper 
panel) and CBB staining (lower panel). Arrowheads indicate the position of 
GST proteins. 
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Figure 4-2 
Figure 4-2. PRMT-1 methylates HSP-60, ATP-2, and Y38F1A.6 in vitro. 
FLAG-PRMT-1 was incubated with GST-HSP-60, GST-ATP-2, GST-
Y38F1A.6, or GST-DAF-16 (FHD) in the presence of [3H]SAM. 
Arrowheads indicate the position of GST proteins in CBB staining (lower 
panel) and their corresponding autoradiography bands (upper panel). FHD, 
forkhead domain. 
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Figure 4-3 
Figure 4-3. Mitochondrial fractionation of whole cell extracts from N2 or 
prmt-1(ok2710) mutants. Each fraction was blotted with antibodies against 
ATP-2 (mitochondrial marker), H3 (nuclear marker), Tubulin (cytoplasmic 
marker), or PRMT-1. TL, total lysate; LM, light mitochondria; HM, heavy 
mitochondria; PMS, post-mitochondria supernatant. 
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CHAPTER 5 
IMPAIRED ATP SYNTHESIS IN MITOCHONDRIA FROM PRMT-1-NULL 
MUTANTS 
 
Purposes 
Mitochondria plays central roles in cellular metabolism. While post-
translational modifications such as phosphorylation and 
acetylation/deacetylation have been shown to closely related to the functions of 
mitochondria (19, 20), the roles of arginine methylation on mitochondrial 
metabolism remains largely unclear. According to the results of Chapter 3 and 
4, asymmetric arginine diemthylation was found on mitochondrial proteins and 
PRMT-1 contributes to almost all the formation of asymmetric arginine 
dimethylation in isolated mitochondria from C. elegans. We next asked if the 
bulk asymmetric arginine methylation on mitochondrial proteins is involved in 
mitochondrial functions.  
 
Results 
It has been shown that mammalian PRMT1 facilitates mitochondrial 
biogenesis through methylation of peroxisome proliferator-activated receptor-γ 
coactivator 1 (PGC1) (27). In C. elegans, however, we did not observe a 
significant reduction in either mitochondrial mass or mRNA levels of 
mitochondrial genes including cyc-1, cco-1 and atp-5 in prmt-1 mutant (Figure 
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5-1). A plausible explanation for this difference may be that PGC1 is not 
conserved in C. elegans. Next, since mitochondria plays central roles in cellular 
metabolism, we assessed the metabolites of N2 and prmt-1(ok2710) mutants 
using the CE-TOFMS-based metabolomics analysis. Based on a comparison of 
the identified 208 metabolites shown in a heatmap, we revealed that a global 
metabolic suppression occurs in prmt-1(ok2710) mutants (Figure 5-2A). In 
particular, the levels of ATP and GSH (glutathione) were decreased in prmt-
1(ok2710) mutants (Figure 5-2B and C, respectively). These data prompted us 
to hypothesize that prmt-1-null mutation may compromise the general functions 
of mitochondria, presumably due to a loss of asymmetric arginine dimethylation 
on a large number of mitochondrial proteins.  
To investigate the functional significance of asymmetric arginine 
dimethylation in mitochondria, we attempted to assess ATP synthesis activity 
using isolated mitochondria fractions. The same amounts of mitochondria 
fraction were prepared from N2 and prmt-1(ok2710) mutants and then subjected 
to in vitro ATP assay (Figure 5-3) with supply of intermediate metabolites 
including pyruvate, succinate, glutamate, and palmitoyl-carnitine, as substrates 
(Figure 5-4). Compared with the N2 control, mitochondria from prmt-1(ok2710) 
mutants exhibited a decrease in ATP production even when any substrate is 
supplied and at any time-course (Figure 5-5A-D).  
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Discussion 
As shown by the results of metabolome analysis, a global suppression of 
energy metabolism, including glycolytic and mitochondrial metabolism, is 
observed in prmt-1 mutant worms. Since the decreased TCA cycle or oxidative 
phosphorylation (OXPHOS) metabolites could be resulted from the 
compromised glycolysis, we employed the in vitro ATP assay with isolated 
mitochondria to directly assess the mitochondrial function under the same 
amount of energy source input and ADP. The combination of pyruvate and 
malate is widely used to assess the function of TCA cycle and OXPHOS, while 
glutamate or succinate with malate is specific to providing electrons through 
complex I or II, respectively. Palmitoyl-L-carnitine, an important intermediate 
of fatty acid metabolism, donates the electrons through the electron transfer 
flavoprotein. Given that each substrate should donate electrons to the electron 
transfer chain via different routes but were all converted to ATP through 
OXPHOS, our data imply that the decreased ATP production of prmt-1(ok2710) 
mutants may be attributed to the defects in OXPHOS, especially the process 
from the complex III, likely due to the loss of asymmetric arginine 
dimethylation on OXPHOS component proteins. 
Notably, ATP-2, which is the beta subunit of the ATP synthase and 
functions in the final step of OXPHOS, is identified as an in vivo substrate of 
PRMT-1. It would be important to examine if the loss of asymmetric arginine 
dimethyaltion on ATP-2 contributes to the defects of OXPHOS resulted from 
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prmt-1 depletion. Previously ATP5B was reported to be phosphorylated, or 
acetylated. However, the functional relevance of these modifications was 
unknown, suggesting the potential obstacles in doing functional study of 
modifications on this protein probably because it’s deeply buried in the inner 
membrane of mitochondria and only functions when assemblies into the 
complex of ATP synthase. Additionally, because the experimental complexity 
of introducing point-mutated protein into C. elegans (usually it takes more than 
three months to generate the transgenic animal), we are planning to assess the 
above issue in more suitable system in future study, such as in mammalian cells. 
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Figure 5-1 
(legend on the next page) 
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Figure 5-1. (A) No significant decrease in mitochondria/body mass ratio was 
observed in prmt-1(ok2710) mutants. Mitochondria mass was obtained by 
calculating from the protein concentration and total volume of the isolated 
mitochondria. The wet-packed worms before mitochondrial fractionation was 
measured for body mass. (B) There was no difference in the expression levels of 
mitochondrial biogenesis genes between N2 (open bar) and prmt-1(ok2710) 
mutants (filled bar). qPT-PCR analysis was performed with total RNA from N2 or 
prmt-1(ok2710) mutants. All genes were normalized to act-1 levels. Error bars 
indicate ± SEM of three independent experiments. n.s.: p > 0.05. 
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Figure 5-2 
(legend on the next page) 
 55 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-2. (A) Metabolomics analysis showed a global metabolic suppression in 
prmt-1(ok2710) mutants. Metabolites from N2 or prmt-1(ok2710) mutants on 
adult day 1 were prepared and then subjected to the CE-MS-based metabolomics 
analysis (Human Metabolome Technologies, Inc.). The identified 208 metabolites 
are clustered and shown in a heatmap. (B and C) The levels of ATP and GSH 
were decreased in prmt-1(ok2710) mutants. The relative peak area was obtained 
from the metabolome analysis results. 
 56 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-3 
Figure 5-3. The isolation of mitochondria fractions for in vitro ATP assay. 
Isolated mitochondria fractions from N2 or prmt-1(ok2710) mutants were 
blotted with anti-H28O16.1 (ATP synthase alpha subunit) or anti-ATP-2 
antibodies. 
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Figure 5-4 
Figure 5-4. The supply of different substrates couples to oxidative 
phosphorylation. The substrates used in in vitro ATP assays are highlighted with 
grey background. Glu, glutamate; succi, succinate; -KG, -ketoglutarate; 
fuma, fumarate; C I-V, complex I-V; ETF, electron transfer flavoprotein; cyc c, 
cytochrome C. 
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Figure 5-5 
A) B) 
C) D) 
Figure 5-5. A-D, ATP synthesis of isolated mitochondria is compromised in prmt-1-
null mutants (filled bar) compared to N2 (open bar). Different combinations of 
substrates were supplied and ATP synthesis was measured by in vitro ATP assay. 
Three independent experiments were performed and the representative results are 
showed. Error bars indicate ± SEM of triplicated measurements. * p < 0.05, ** p < 
0.01, *** p < 0.001. 
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CHAPTER 6 
INCREASED MITOCHONDRIAL ROS PRODUCTION AND 
MITOCHONDRIAL STRESS RESPONSES IN PRMT-1-NULL MUTANTS 
 
Purposes 
The isolated mitochondria from prmt-1 mutant worms exhibited decreased 
ATP synthesis ability when supplied with different electron donors in vitro, 
indicating possible defects in OXPHOS function. In this chapter, we are aiming 
to seek for biological outcomes as the evidence of impaired OXPHOS. 
Mitochondria is the major source of cellular ROS production, and any 
perturbations that cause the drop of potential across the inner membrane likely 
increase the mitochondrial ROS generation. Since cells use glutathione (GSH) 
to reduce the oxidized macromolecules by high level of ROS, it is expected to 
observe the up-regulation of the response against oxidative stress and a decrease 
in cellular GSH level. On the other hand, loss of asymmetric arginine 
dimethylation on mitochondrial proteins could probably obstruct their proper 
folding, and the suboptimal folding could either cause the malfunction of the 
proteins or even the unfolded protein stress in mitochondria. Therefore, we also 
intended to examine the mitochondria-specific unfolded protein response 
(UPRmt) for the role of asymmetric arginine methylation on mitochondrial 
proteins in terms of protein folding. 
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Results 
Abnormal OXPHOS often couples with the decreased mitochondrial 
membrane potential and subsequent electron leak, which in turn leads to 
reactive oxygen species (ROS) production (28–30). To ascertain whether prmt-
1(ok2710) mutants increase the ROS production in mitochondria, we used the 
mitochondrial superoxide indicator MitoSOX for in vivo imaging. As shown in 
Figure 6-1, mitochondrial ROS was selectively detected in prmt-1(ok2710) 
mutants. Importantly, the prmt-1 revertant strain that fully restores the amount 
of ADMA (19) exhibited an elimination of mitochondrial ROS, whereas another 
revertant strain harboring an enzymatically-inactive prmt-1G70A failed to 
attenuate the increase of ROS production in the prmt-1 null allele. In contrast to 
PRMT-1, depletion of PRMT-5, the predominant type II arginine 
methyltransferse in C. elegans (Kanou et. al, submitted for publication), had no 
effect on mitochondrial ROS levels (Figure 6-2). Considering the results of in 
vitro ATP assay (Figure 5-5), these findings suggest that asymmetric arginine 
dimethylation by PRMT-1 contributes to normal OXPHOS in C. elegans. 
Next, we further examined whether the impairment of mitochondrial 
function triggered by ablation of prmt-1 could result in mitochondrial stress. 
Quantitative RT-PCR demonstrated elevation of a wide range of the 
mitochondrial stress response genes including oxidative stress, xenobiotic-
detoxification, and pathogen-response pathway in prmt-1(ok2710) mutants 
(Figure 6-3). In addition, gene ontology analysis of DNA microarray of N2 and 
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prmt-1(ok2710) mutants revealed a global up-regulation of genes, especially 
those associated with metabolic processes and mitochondrial functions (Figure 
6-4), suggesting that prmt-1-null mutants exhibit the adaptive responses to 
mitochondrial dysfunction. 
Mitochondrial unfolded protein response (UPRmt) is an evolutionarily 
conserved system that confers resistance to mitochondrial stresses by up-
regulating mitochondria-specific chaperones, such as HSP-6 or HSP-60 (8, 31). 
To investigate whether loss of asymmetric arginine dimethylation in 
mitochondrial proteins could elicit the UPRmt, we employed a highly sensitive 
reporter strain zcIS13[Phsp6::gfp] that induces hsp-6 promoter-driven GFP 
expression specifically responding to mitochondrial stresses (8, 32). As shown 
in Figure 6-5A, knockdown of prmt-1 led to an restricted induction of GFP in 
the head and tail compared with control knockdown. The activation of the hsp-6 
promoter by prmt-1 knockdown was confirmed by Western blot with GFP 
antibody (Figure 6-5B). Together with a marked decrease in GSH level (Figure 
5-2C), these observations clearly show that loss of PRMT-1 induces 
mitochondrial stress, perhaps as a result of disruption of redox homeostasis in 
C. elegans. 
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Discussion 
As revealed by the results of MitoSOX staining, prmt-1 mutant worms 
exhibited increased level of mitochondrial ROS generation. Since the ROS 
elevation was rescued by the prmt-1 wild-type but not enzymatically-deficient 
transgenic revertants, we suppose that the increased ROS generation was due to 
the loss of asymmetric arginine dimethylation on mitochondrial proteins which 
is necessary for the normal function of OXPHOS. 
Compared to the positive control isp-1, the induction of mitochondrial 
UPRmt indicated by hsp6p::gfp was relatively weak that GFP only observed in 
the pharynx and the end of intestine of prmt-1 KD while in the whole intestine 
of isp-1 KD (data not shown). Although it may be due to a problem of the 
incomplete deletion of prmt-1 by knockdown (we were unable to examine the 
activation of UPRmt by using the hsp6p::gfp reporter line in prmt-1 mutant 
worms since the transgenic gene is on the same chromosome with prmt-1 gene 
and this makes it difficult to introduce the hsp6p::gfp gene into the prmt-1 
mutant background by mating), the weak GFP induction suggested a mild 
mitochondrial stress when prmt-1 is depleted. On the other hand, asymmetric 
arginine dimethylation could occur on a broad spectrum of mitochondrial 
proteins as shown by the study in Trypanosome (29). Although the complete 
depletion of crucial mitochondrial proteins including ATP-2 or HSP-60 causes 
the activation of UPRmt in C. elegans, it is highly possible that the mild 
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mitochondrial stress in prmt-1 depleted worms is an integrated result of the loss 
of asymmetric arginine methylation on global mitochondrial proteins. 
Whether the activation of UPRmt was related to the elevated mitochondrial 
ROS remains an interesting issue to be addressed. Currently we are trying to 
examine the level of UPRmt when mitochondrial ROS is blocked by antioxidant 
such as N-acetyl-cysteine (NAC). 
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Figure 6-1 
Figure 6-1. N2, prmt-1(ok2710), Ex71[prmt-1(+)];prmt-1(ok2710), or 
Ex84[prmt-1G70A(+)];prmt-1(ok2710) on adult day 1 was stained with the 
mitochondrial superoxide indicator MitoSOX and observed with a fluorescent 
microscope. Representative microscopy images (original magnification 400×) are 
shown. DIC, different interference contrast. 
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Figure 6-2 
Figure 6-2. Feeding RNAi was carried out with control L4440, prmt-1, or prmt-5 
RNAi vectors from L4 stage. The F1 generation on adult day 1 was stained with 
the mitochondrial superoxide indicator MitoSOX. Representative microscopy 
images (original magnification 400×) are shown. DIC, different interference 
contrast. 
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Figure 6-3 
Figure 6-3. prmt-1-null mutants (filled bar) show elevated expression of 
genes involved in oxidative-stress-response, xenobiotic-detoxification, and 
pathogen-response pathways relative to N2 (open bar). qPT-PCR analysis 
was performed with total RNA from N2 or prmt-1(ok2710) mutants. All 
genes were normalized to act-1 levels. Error bars indicate ± SEM of two 
independent experiments. 
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Figure 6-4 
(legend on the next page) 
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Figure 6-4. (A) Genes related to metabolic process were enriched from 
total up-regulated genes in prmt-1(ok2710) mutants. Over 2-fold up-
regulated genes identified by DNA microarray were functionally 
categorized through the Database for Annotation, Visualization, and 
Integrated Discovery (DAVID). Enrichment p value less than 0.05 was 
shown. (B and C) Seventy-four genes related to metabolic process and 
fourteen genes related to mitochondrial function were up-regulated in 
prmt-1(ok2710) mutants. Over 2-fold up-regulated genes were categorized 
through DAVID according to gene functions or cellular compartments. 
Metabolic and mitochondrial genes were shown by two heatmaps (B) and 
(C), respectively. 
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Figure 6-5 
A) B) 
Figure 6-5. Knockdown of prmt-1 induces GFP expression in the 
mitochondrial stress reporter strain zcIS13[Phsp6::gfp]. Feeding RNAi was 
carried out with control L4440 or prmt-1 RNAi vectors from L4 stage. GFP 
expression was observed in the F1 generation with a fluorescent 
microscope (A) and Western blot with anti-GFP antibody (B). DIC, 
different interference contrast. 
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CHAPTER 7 
MITOCHONDRIAL DYSFUNCTION-INDUCED FOOD-AVOIDANCE IN 
PRMT-1-NULL MUTANTS 
 
Purposes 
Since PRMT-1 is the only type I PRMT in C. elegans, and the null mutant 
worm of prmt-1 is available unlike it is in mouse or fruit fly, it seems that C. 
elegans is an ideal animal model to study the physiological functions of 
asymmetric arginine dimethylation. Previously, we reported that the 
transcriptional factor and orthologue of FOXO-1, DAF-16 is a substrate of 
PRMT-1 in C. elegans, and the asymmetric arginine dimethylation of DAF-16 
acts as an anti-ageing switch which antagonizes the inhibitory effect of 
phosphorylation on DAF-16 by AKT-1 (9). In current study, we discovered that 
PRMT-1 contributes to almost all the asymmetric arginine dimethylation 
formation on mitochondrial proteins in C. elegans, and the loss of PRMT-1-
mediated arginine methylation resulted in compromised mitochondrial function 
and increased mitochondrial ROS generation and stress responses in C. elegans. 
Next, we searched for any phenotypic changes of prmt-1 mutant worms that 
may be related to the mitochondrial dysfunction to further elucidate the 
physiological roles of asymmetric arginine dimethylation. 
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Results 
It is known that C. elegans interprets compromised mitochondrial function 
as xenobiotic or pathogen attack, and thereby tend to avoid food intake even if 
the food does not contain pathogenic bacteria (7, 8). To examine the behavioral 
response to the mitochondrial dysfunction caused by loss of asymmetric 
arginine dimethylation, we performed food-avoidance experiments. As shown 
in Figure 6A, prmt-1(ok2710) mutants exhibited a dispersed feeding behavior in 
contrast to wild-type N2. It should be noted that this phenotype was similar to 
that caused by depletion of isp-1 (Figure 6A), which encodes a component of 
the mitochondrial complex III in the electron transport chain and loss-of-
function mutant of isp-1 has been shown to increase ROS production and 
activate UPRmt (8, 29, 30). To determine whether the food-avoidance phenotype 
of prmt-1(ok2710) mutants indeed results from mitochondrial dysfunction, we 
performed epistasis analysis with RNAi against surveillance genes, inx-17 or 
thoc-2, that has been identified to be involved in food-avoidance downstream of 
mitochondrial dysfunction (8). As expected, silencing inx-17 or thoc-2 in prmt-
1(ok2710) mutants completely suppressed the food-avoidance phenotype 
(Figure 6B). These findings suggest that food-avoidance behavior of prmt-1-
null mutants is attributed to mitochondrial dysfunction due to loss of 
asymmetric arginine dimethylation in mitochondria. 
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Discussion 
Food-avoidance exhibited by C. elegans represents for an innate defensive 
behavior when they encounter the pathogenic foods. Like depletion of other key 
proteins in mitochondria, loss of PRMT-1 resulted in food-avoidance when fed 
on even non-pathogenic bacteria lawn, indicating that C. elegans interprets the 
disruption of core cellular functions such as mitochondrial metabolism as 
pathogen attracts. Indeed, the expression levels of stress response genes related 
to innate immunity elevated in prmt-1 mutant worms. 
Since food-avoidance can be observed not only when mitochondrial 
function is compromised, but also with defects in other core cellular functions, 
such as endoplasm reticulum, translation, or cytoplasmic protein folding. The 
results that silencing the mitochondria-specific surveillance genes in prmt-1 
mutant worm blocked the food-avoidance behavior confirmed that the 
phonotype is attributed to the mitochondrial dysfunction. Actually, these 
mitochondria-specific surveillance genes were identified as being able to block 
the UPRmt, and our results further proved that UPRmt is the upstream molecular 
event of mitochondria-related food-avoidance. 
However, the relation between elevated mitochondrial ROS and food-
avoidance in prmt-1 mutant worms remains to be investigated in the following 
study. 
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Figure 7-1 
(legend on the next page) 
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Figure 7-1. Loss of enzymatic activity of prmt-1 induces food avoidance behavior. 
(A) prmt-1 mutant and isp-1 knockdown worms exhibit food avoidance behavior in 
contrast to controls. Representative images of N2 or prmt-1 mutants (left), and N2 fed 
on control L4440 or isp-1 RNAi plates (right) are shown. (B) The quantified results of 
the food avoidance phenotype in (A) are shown. Error bars indicate ± SEM of three 
independent experiments. n.s. p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001. 
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Figure 7-2 
(legend on the next page) 
A) 
B) 
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Figure 7-2. Loss of prmt-1 induces food-avoidance mediated by mitochondrial 
stress. (A) The food avoidance phenotype exhibited in prmt-1 mutants is 
suppressed by silencing of surveillance genes for mitochondrial stress. 
Representative images of N2 or prmt-1 mutants fed on control L4440, inx-17, or 
thoc-2 RNAi plates are shown. Arrowheads. (B) The quantified results of the food 
avoidance phenotype in (A) are shown. Error bars indicate ± SEM of three 
independent experiments. n.s. p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001.  
indicate the off-lawn worms. 
 77 
CHAPTER 8 
SUMMARY 
In this study, we used C. elegans as a suitable multi-cellular model for 
screening in vivo substrates of PRMT-1 with the strategy of 2-D proteomic 
analysis based on Western blot against two distinct ADMA antibodies (Figure 
3-1). We identified nine proteins modified by asymmetric arginine 
dimethylation in vivo (Figure 3-3 and Table 1). Of nine substrates, a nuclear 
receptor NHR-12 isoform c is the ortholog of mammalian HNF4 that has been 
known to be regulated by PRMT1 in a methylation-dependent manner (33). 
Additionally, the identification of ribosomal RPL-4 and RPS-4 leads us to 
assume a similarity to recent findings that arginine methylation of mammalian 
RPS2 and RPS3 are involved in ribosomal assembly and biogenesis (34–36). 
Thus, our present results raise the possibility that asymmetric arginine 
dimethylation may play indispensable roles in transcriptional and translational 
regulation spanning a wide range of organisms. 
An elusive issue should be addressed is where PRMT-1 binds to and 
methylates the three mitochondrial proteins (Figure 4-1 and 4-2) identified in 
the 2-D proteomic study (Figure 3-3 and Table 1). Furthermore, loss of PRMT-
1 abolishes almost all the ADMA formation in mitochondria (Figure 4-4). 
Together, these results demonstrate that PRMT-1 is the responsible enzyme for 
asymmetric arginine dimethylation on mitochondrial proteins. Based on this 
 78 
finding, C. elegans should be an ideal model for investigating whether the bulk 
asymmetric arginine dimethylation contributes to mitochondrial functions.  
Intriguingly, as demonstrated by the subcellular fractionation (Figure 4-3), 
PRMT-1 is not localized in the mitochondria of C. elegans and we have also 
observed a similar result in human cells (data not shown). These results suggest 
that, unlike other posttranslational modifications such as phosphorylation and 
acetylation (11, 12), asymmetric arginine dimethylation of mitochondrial 
proteins doesn’t occur within the mitochondria. Alternatively, given that over 
99% of mitochondrial proteins are encoded by nuclear genome, they appear to 
be methylated simultaneously with translation in the cytoplasm before 
mitochondrial import. If so, it would add another layer of regulation to 
mitochondrial homeostasis potentially by modulating the transport of 
mitochondrial proteins in response to the intracellular environment. 
Loss of asymmetric arginine dimehtylation in mitochondria results in 
decreased ATP synthesis activity (Figure 5-5). It is notable that ATP-2, a key 
component of ATP synthase, is identified as a substrate of PRMT-1 in current 
study. Remarkably, a global mass spectrometric analysis of Trypanosoma 
brucei, an early branching single-cell eukaryote, has reported that 54 and 13 
mitochondrial proteins are asymmetrically and symmetrically dimethylated, 
respectively, and many of them are implicated in OXPHOS function (25). 
Considering these data together with our current findings, impairment in ATP 
synthesis of the prmt-1-null mitochondria may be attributed to loss-of 
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asymmetric arginine dimethylation on overall mitochondrial substrate proteins 
including ATP-2. In this meaning, our study for the first time bridged the 
asymmetric arginine dimethylation of mitochondrial proteins to fundamental 
mitochondrial function. 
We provided evidence that enzymatic activity of PRMT-1 contributes to 
suppress mitochondrial ROS generation (Figure 6-1) probably by maintaining 
the OXPHOS function, while knockdown of PRMT-5, the major type II 
arginine methyltransferase in C. elegans (Kanou, et al. submitted), had no effect 
on that function (Figure 6-2). These results imply that symmetric arginine 
dimethylation at least by PRMT-5 is not necessary for normal OXPHOS 
function. However, instead of PRMT-5, non-canonical methyltransferase 
NDUFAF7 included in the matrix of mitochondria has been shown to methylate 
NDUFS2, a subunit of mitochondrial complex I, and thereby serve to assemble 
complex I (14), suggesting that, unlike asymmetric, symmetric arginine 
dimethylation on mitochondrial proteins are regulated by previously 
unidentified type II arginine methyltransferase(s) localized in mitochondria. 
Further investigations are needed to determine the functional difference 
between asymmetric and symmetric arginine dimethylation on mitochondrial 
proteins. 
As a behavioral response to the mitochondrial dysfunction of prmt-1-null 
mutants, we observed food avoidance behavior (Figure 7-1) that is thought to be 
a defensive phenotype to protect core cellular functions including mitochondrial 
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respiration (7); because C. elegans living in microbe-rich environment is 
persistently attacked by pathogenic bacteria with their mitochondria easily 
targeted as valuable source of iron (37, 38). Meanwhile, despite that food does 
not contain pathogenic bacteria, mitochondrial dysfunction leads to food 
avoidance behavior, possibly by interpreting the mitochondrial defects as 
pathogen attack (8). In agreement with this idea, we found up-regulation of 
genes involved in xenobiotic-detoxification and natural immune response in 
prmt-1-null mutants (Figure 6-3). Furthermore, genetic analysis demonstrated 
that food-avoidance of prmt-1-null mutants can be blocked by silencing either 
thoc-2 or inx-17 (Figure 7-2), both of which have been recently identified as 
mitochondrial surveillance genes (8). THOC-2 has been shown to be an mRNA-
binding protein facilitating nuclear export of mRNA and required for proper 
neuronal development (39), while the function of INX-17, which expresses 
abundantly in interneurons, is still unknown. Although the detailed mechanisms 
underlying food avoidance by mitochondrial dysfunction remain unclear, it is 
possible that loss of asymmetric arginine dimethylation induces this defensive 
behavior through the same pathway and neuronal circuits as that induced by 
inhibition of OXPHOS components (e.g. isp-1) because of the stress responses 
triggered by them are similar (28–30). Importantly, the depletion of atp-2 or 
hsp-60 in C. elegans induces UPRmt (18, 40) and food-avoidance behavior (7), 
strongly indicating that PRMT-1 serves as a positive regulator of mitochondrial 
function by methylating its substrates including ATP-2 and HSP-60. 
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In conclusion, we identified in vivo substrates of C. elegans PRMT-1 at the 
whole-body level. This is the first evidence that links asymmetric arginine 
dimethylation of mitochondrial proteins to ATP synthesis activity and 
mitochondrial homeostasis. Our study adds new evidence to the diverse 
regulations of mitochondrial proteins by post-translational modifications. It is 
speculated that arginine methylation, like phosphorylation or acetylation, may 
represent for a strategy employed by eukaryotic cells to regulate the 
mitochondria, originally engulfed as -proteobacteria (2), to meet the cellular 
energy demands. 
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